MRNA Oct 2024 70.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 11:56AM EDT. Market open.
| Previous Close | 54.42 |
| Open | 43.47 |
| Bid | 64.40 |
| Ask | 65.30 |
| Strike | 70.00 |
| Expire Date | 2024-10-18 |
| Day's Range | 43.47 - 54.42 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 43 |
ZacksBiotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
Novavax, Inc (NVAX) and Fulcrum Therapeutics, Inc (FULC) are in the spotlight following license agreements with pharma giant Sanofi.
Investor's Business DailyModerna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Moderna is on the rise after the Food and Drug Administration delayed a decision on its RSV vaccine. But is MRNA stock, once again, a buy?
ZacksModerna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Moderna's (MRNA) RSV vaccine, mRNA-1345's review timeline gets delayed. A decision is now expected by the end of May.
© 2024 Yahoo. All rights reserved.